n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with metergoline in 1 studies
| Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (metergoline) | Trials (metergoline) | Recent Studies (post-2010) (metergoline) |
|---|---|---|---|---|---|
| 79 | 1 | 16 | 656 | 37 | 44 |
| Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | metergoline (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.0007 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.366 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.0041 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.058 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.2 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.063 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.016 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.189 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0062 | |
| Substance-K receptor | Homo sapiens (human) | 4.071 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.074 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.344 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.366 | |
| Histamine H2 receptor | Homo sapiens (human) | 0.975 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.136 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0007 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0062 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.59 | |
| Histamine H1 receptor | Homo sapiens (human) | 4.133 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0077 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.028 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.063 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and metergoline
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |